0001654954-24-007461.txt : 20240606
0001654954-24-007461.hdr.sgml : 20240606
20240606182645
ACCESSION NUMBER: 0001654954-24-007461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marchiando Keith
CENTRAL INDEX KEY: 0001291432
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40449
FILM NUMBER: 241026699
MAIL ADDRESS:
STREET 1: C/O ZIVO BIOSCIENCE, INC.
STREET 2: 21 E. LONG LAKE ROAD, SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zivo Bioscience, Inc.
CENTRAL INDEX KEY: 0001101026
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870699977
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
BUSINESS PHONE: (248) 452 9866
MAIL ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC
DATE OF NAME CHANGE: 20040202
FORMER COMPANY:
FORMER CONFORMED NAME: WESTERN GLORY HOLE INC
DATE OF NAME CHANGE: 19991215
4
1
section16.xml
FORM 4
X0508
4
2024-06-05
0001101026
Zivo Bioscience, Inc.
ZIVO
0001291432
Marchiando Keith
C/O ZIVO BIOSCIENCE, INC.
21 EAST LONG LAKE ROAD, SUITE 100
BLOOMFIELD HILLS
MI
48304
false
true
false
false
Chief Financial Officer
false
Nonstatutory Stock Option to Purchase Common Stock
67.20
2024-06-05
4
D
false
27083
D
2030-12-31
Common Stock
27083
0
D
Nonstatutory Stock Option to Purchase Common Stock
33.00
2024-06-05
4
D
false
48000
D
2031-10-20
Common Stock
48000
0
D
Nonstatutory Stock Option to Purchase Common Stock
23.64
2024-06-05
4
D
false
10333
D
2032-08-28
Common Stock
10333
0
D
Nonstatutory Stock Option to Purchase Common Stock
7.96
2024-06-05
4
A
false
444498
A
2034-06-04
Common Stock
444498
444498
D
The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 80 reverse stock split of the Issuer's stock in May 2021 and a 1 for 6 reverse stock split of the Issuer's stock in October 2023, as applicable.
The canceled option was fully vested.
The Issuer canceled options for an aggregate 85,416 shares of the Issuer's common stock granted to the Reporting Person on 1/1/2021, 10/21/2021, and 8/29/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 444,498 shares, having an exercise price of $7.96.
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 10/21/2021 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 8/29/2022 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 328,065 immediately upon grant acceptance, 13,551 on July 1, 2024, 13,442 on August 28, 2024, 62,447 on October 21, 2024, 13,551 on January 1, 2025, and 13,442 on August 28, 2025.
/s/ Keith Marchiando
2024-06-06